URBN
Analyst Coverage
Cannabis Investor News in-house rating · cin-analyst-v1.0
Urban-Gro earns an Underweight rating, with a composite score in the high 20s and low conviction at two out of five. Regulatory is the strongest pillar at 49, supported by an 80 enforcement subscore, a 50 jurisdiction assessment, and no enforcement hits. Market contributes 40 despite the absence of an available quote from institutional pricing feeds, limiting confirmation of trading momentum and valuation support. Editorial contributes 30, reflecting no newsroom or brief activity in CIN newsroom coverage. Fundamentals contribute only 3, making operating performance the decisive drag on the rating. The resulting profile combines modest regulatory support with weak financial execution, limited market visibility, and no incremental editorial signal.
Licensed fundamentals data show year-over-year revenue contracting by roughly 70%, while gross margin stands near 1%. Operating margin is approximately negative 109%, demonstrating that the current revenue base remains far below the level required to absorb operating costs. Net loss exceeds $21 million, and EBITDA is negative by roughly $17 million; those figures reinforce the stretched financial condition rather than indicating a viable earnings inflection. Market capitalization sits below $5 million, while the cash-burn ratio is about 3.45 and the cash-runway subscore reaches only 15. Primary regulatory filings also provide limited cadence support: no latest filing date is available, the cadence subscore is 25, and no regulatory events were recorded across either the 90-day or 180-day windows. The lack of filing recency constrains visibility into any subsequent change in revenue quality, cost structure, or capital resources.
The clearest forward catalyst sits within the regulatory pillar, already the company’s strongest contributor. Continued absence of enforcement hits preserves the pillar’s highest-scoring driver, but a material rerating requires current primary regulatory filings that establish improved disclosure cadence and provide updated evidence on operating performance. Fresh filings could strengthen the 25 cadence subscore while allowing the market to evaluate whether steep revenue contraction, minimal gross profitability, negative EBITDA, and the bottom-line loss are moderating. Until that evidence appears, regulatory strength remains defensive rather than transformational, and the weak fundamentals pillar anchors the Underweight band. The single most important signal to watch is the publication of a current primary regulatory filing that restores cadence and documents measurable operating improvement.
- IR / PR agency
- ICR, Inc.
- IR email
- Investors@flashsm.com
- IR page
- Investor relations
- Headquarters
- 5000 SOUTH BROAD STREET, PHILADELPHIA, PA, 19112
- Phone
- 2154545500
- CEO
- Bradley Nattrass
- CFO
- Eric Sherb
- SEC CIK
- 912615
- Website
- Company website
- Market cap
- $4.9M
- Enterprise value
- $100.9M
- Price to book
- 0.77
- Price to sales
- 0.28
- EV / EBITDA
- -1.82
- Revenue (TTM)
- $17.4M
- Gross profit (TTM)
- $175K
- EBITDA
- $-17.1M
- Operating margin
- -108.9%
- Profit margin
- -122.8%
- Rev growth YoY
- -70.1%
- Return on equity
- -27.7%
- Return on assets
- -8.5%
- EPS (TTM)
- $-42.62
- EPS est. current year
- $-6.50
- Wall St. target price
- $57.50
- Shares outstanding
- 1.6M
- Insider ownership
- 5.7%
- Institutional ownership
- 3.1%
- Beta
- -2.90
- Full-time employees
- 5
- GICS sector
- Communication Services
- GICS industry
- Broadcasting
- Annual report
- Latest 10-K
- Proxy statement
- Latest DEF 14A
- Filing portal
- SEC EDGAR
Help us keep coverage accurate. Submit an update for CIN editorial review.
Bullish and Bearish Analyst Opinions for URBN (URBN)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for URBN (URBN), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for URBN are maintained by Cannabis Investor News and refreshed throughout the trading day.